Why the study?
Does brain natriuretic peptide (BNP) level predict heart failure and pregnancy complications in pregnant women with congenital heart defects?
Does brain natriuretic peptide (BNP) level predict heart failure and pregnancy complications in pregnant women with congenital heart defects?
BNP levels during pregnancy in women with congenital heart defects can serve as a diagnostic and prognostic marker for heart failure and pregnancy complications, aiding in clinical management.
Answers are grounded in this paper and cite their sources.
BNP may aid risk stratification in pregnant women with congenital heart disease; hypothesis-generating and requires prospective validation before practice change.
The fi rst study in Ukraine on the analysis of the level of brain natriuretic peptide (BNP) in pregnancy in women with congenital heart defects was performed. The results of this study showed that the level of BNP is a valuable diagnostic and prognostic marker of heart failure and a predictor of pregnancy complications in women with congenital heart defects. Due the value of BNP growth in pregnancy it can predict the tactics of pregnancy, timing and nature of the delivery, to develop individual therapy indications for maintenance of pregnancy.
No takes yet. Share an insight, caveat, or question.
Давыдова et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: